Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

Kato, Masaki, Patel, Millan S., Levasseur, Regis, Lobov, Ivan, Chang, Benny H.-J., Glass, Donald A., Hartmann, Christine, Li, Lan +5 more·2002·The Journal of Cell Biology

Cited by (999)

Items 101–200 of 999

  1. Expression Profiling and Functional Analysis of Wnt Signaling Mechanisms in Mesenchymal Stem Cells
    S. Leah Etheridge, Gary J. Spencer, Deborah J. Heath, Paul G. Genever · 2004 · Stem Cells
  2. Decreased BMD and Limb Deformities in Mice Carrying Mutations in Both Lrp5 and Lrp6
    Sheri L. Holmen, Troy A. Giambernardi, Cassandra R. Diegel, Bree D. Buckner-Berghuis, James H. Resau, J. Fred Hess, Vaida Glatt, Mary Bouxsein, Minrong Ai, Matthew L. Warman et al. · 2004 · Journal of Bone and Mineral Research
  3. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2
    Takashi Oshima, Masahiro Abe, Jin Asano, Tomoko Hara, Ken-ichi Kitazoe, Etsuko Sekimoto, Yoïchi Tanaka, Hironobu Shibata, Toshihiro Hashimoto, Shuji Ozaki et al. · 2005 · Blood
  4. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation
    Xiaofeng Li, Peng Liu, Wenzhong Liu, Peter F. Maye, Jianghong Zhang, Yazhou Zhang, Marja M. Hurley, Caiying Guo, Adele L. Boskey, Le Sun et al. · 2005 · Nature Genetics
  5. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro
    Gary J. Spencer, Jennifer C. Utting, S. Leah Etheridge, Timothy R. Arnett, Paul G. Genever · 2006 · Journal of Cell Science
  6. Msx2 Promotes Osteogenesis and Suppresses Adipogenic Differentiation of Multipotent Mesenchymal Progenitors
    Su‐Li Cheng, Jian-Su Shao, Nichole Charlton-Kachigian, Arleen P. Loewy, Dwight A. Towler · 2003 · Journal of Biological Chemistry
  7. Runx2: A master organizer of gene transcription in developing and maturing osteoblasts
    Tania M. Schroeder, Eric D. Jensen, Jennifer J. Westendorf · 2005 · Birth Defects Research Part C Embryo Today Reviews
  8. Gone with the Wnts: β-Catenin, T-Cell Factor, Forkhead Box O, and Oxidative Stress in Age-Dependent Diseases of Bone, Lipid, and Glucose Metabolism
    Stavros C. Manolagas, Maria Almeida · 2007 · Molecular Endocrinology
  9. BMP-2 and Insulin-like Growth Factor-I Mediate Osterix (Osx) Expression in Human Mesenchymal Stem Cells via the MAPK and Protein Kinase D Signaling Pathways
    Ayse B. Celil, Phil G. Campbell · 2005 · Journal of Biological Chemistry
  10. A Wnt canon orchestrating osteoblastogenesis
    Christine Hartmann · 2006 · Trends in Cell Biology
  11. Noncanonical Wnt Signaling through G Protein-Linked PKCδ Activation Promotes Bone Formation
    Xiaolin Tu, Kyu Sang Joeng, Keiko Nakayama, Keiko Nakayama, Jayaraj Rajagopal, Thomas J. Carroll, Andrew P. McMahon, Fanxin Long · 2007 · Developmental Cell
  12. Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches
    ERNESTO M. CANALIS · 2013 · Nature Reviews Endocrinology
  13. Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
    Terence M. Doherty, Lorraine A. Fitzpatrick, Daisuke Inoue, Jian-Hua Qiao, Michael C. Fishbein, Robert Detrano, Prediman K. Shah, Tripathi B. Rajavashisth · 2004 · Endocrine Reviews
  14. Wnt signaling and cellular metabolism in osteoblasts
    Karner, Courtney M., Long, Fanxin · 2017 · Cellular and Molecular Life Sciences
  15. The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice
    Olivia Kelly, Kathy I. Pinson, William C. Skarnes · 2004 · Development
  16. Wnt signaling and osteoblastogenesis
    Peter V.N. Bodine, Barry S. Komm · 2006 · Reviews in Endocrine and Metabolic Disorders
  17. Osteoblasts: novel roles in orchestration of skeletal architecture
    Eleanor J. Mackie · 2003 · The International Journal of Biochemistry & Cell Biology
  18. Effects of Wnt Signaling on Proliferation and Differentiation of Human Mesenchymal Stem Cells
    Jan de Boer, Hong Jun Wang, Clemens van Blitterswijk · 2004 · Tissue Engineering
  19. Wnt/β-Catenin Signaling Is a Component of Osteoblastic Bone Cell Early Responses to Load-bearing and Requires Estrogen Receptor α
    Victoria J. Armstrong, Mariusz Muzylak, Andrew Sunters, Gul Zaman, Leanne Saxon, J. S. Price, Lance E. Lanyon · 2007 · Journal of Biological Chemistry
  20. Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
    Luigi Gennari, Daniela Merlotti, Roberto Valenti, Elena Ceccarelli, Martina Ruvio, María G. Pietrini, Cosimo Capodarca, Maria Beatrice Franci, Maria Stella Campagna, Anna Calabrò et al. · 2012 · The Journal of Clinical Endocrinology & Metabolism
  21. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts
    Keizo Ohnaka, Mizuho Tanabe, Hisaya Kawate, Hajime Nawata, Ryoichi Takayanagi · 2005 · Biochemical and Biophysical Research Communications
  22. Atorvastatin Inhibits Hypercholesterolemia-Induced Calcification in the Aortic Valves via the Lrp5 Receptor Pathway
    Nalini Marie Rajamannan, Malayannan Subramaniam, Frank C. Caira, Stuart R. Stock, Thomas C. Spelsberg · 2005 · Circulation
  23. WNT as a Driver and Dependency in Cancer
    Parsons, Marie J., Tammela, Tuomas, Dow, Lukas E. · 2021 · Cancer Discovery
  24. New Insights into the Mechanism of Wnt Signaling Pathway Activation
    Akira Kikuchi, Hideki Yamamoto, Akira Sato, Shinji Matsumoto · 2011 · International review of cytology
  25. The WNT system: background and its role in bone
    Ulf H. Lerner, Claes Ohlsson · 2015 · Journal of Internal Medicine
  26. Reduced Affinity to and Inhibition by DKK1 Form a Common Mechanism by Which High Bone Mass-Associated Missense Mutations in LRP5 Affect Canonical Wnt Signaling
    Minrong Ai, Sheri L. Holmen, Wim Van Hul, Bart O. Williams, Matthew L. Warman · 2005 · Molecular and Cellular Biology
  27. Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
    Deborah J Heath, Andrew Chantry, Clive Buckle, Les Coulton, John D. Shaughnessy, Holly Evans, John Andrew Snowden, David R. Stover, Karin Vanderkerken, Peter Ian Croucher · 2008 · Journal of Bone and Mineral Research
  28. Wnt and the Wnt signaling pathway in bone development and disease
    Yi‐Ping Wang · 2014 · Frontiers in bioscience
  29. Polymorphisms in the Low-Density Lipoprotein Receptor–Related Protein 5 (LRP5) Gene Are Associated with Variation in Vertebral Bone Mass, Vertebral Bone Size, and Stature in Whites
    Serge Ferrari, Samuel Deutsch, Urmila Choudhury, Thierry Chevalley, Jean‐Philippe Bonjour, Emmanouil T. Dermitzakis, René Rizzoli, Stylianos E. Antonarakis · 2004 · The American Journal of Human Genetics
  30. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice
    Mortaza Jabbarpour Bonyadi, Stephen D. Waldman, Danmei Liu, Jane E. Aubin, Marc D. Grynpas, William L. Stanford · 2003 · Proceedings of the National Academy of Sciences
  31. Regulation of Bone Remodeling by Parathyroid Hormone
    Marc Nathan Wein, Henry M. Kronenberg · 2018 · Cold Spring Harbor Perspectives in Medicine
  32. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells
    Jan de Boer, Ramakrishnaiah Siddappa, Claudia Gaspar, Aart A. van Apeldoorn, Riccardo Fodde, Clemens van Blitterswijk · 2004 · Bone
  33. The role of magnesium ions in bone regeneration involves the canonical Wnt signaling pathway
    Hung, Chu-Chih, Chaya, Amy, Liu, Kai, Verdelis, Konstantinos, Sfeir, Charles · 2019 · Acta Biomaterialia
  34. A Model for mechanotransduction in bone cells: The load‐bearing mechanosomes
    Fred M. Pavalko, Suzanne M. Norvell, David B. Burr, Charles H. Turner, Randall L. Duncan, Joseph P. Bidwell · 2002 · Journal of Cellular Biochemistry
  35. Wnt signaling as a therapeutic target for bone diseases
    Luke H. Hoeppner, Frank J. Secreto, Jennifer J. Westendorf · 2009 · Expert Opinion on Therapeutic Targets
  36. Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis
    Maurizio Rossini, Davide Gatti, Silvano Adami · 2013 · Calcified Tissue International
  37. Coordinated Activation of Notch, Wnt, and Transforming Growth Factor-β Signaling Pathways in Bone Morphogenic Protein 2-induced Osteogenesis
    Natasa Zamurovic, David Cappellen, Daisy Rohner, Mira Šuša · 2004 · Journal of Biological Chemistry
  38. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation
    Alka Mansukhani, Davide Carlo Ambrosetti, Greg Holmes, Lizbeth Cornivelli, Claudio Basilico · 2005 · The Journal of Cell Biology
  39. Physiological role of collagen XVIII and endostatin
    Alexander G. Marneros, Bjorn Reino Olsen · 2005 · The FASEB Journal
  40. BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling
    Ni Tang, Wenxin Song, Jinyong Luo, Xiaoji Luo, Jin Chen, Katie A. Sharff, Yang Bi, Bai‐Cheng He, Jiayi Huang, Gaohui Zhu et al. · 2008 · Journal of Cellular and Molecular Medicine
  41. Regulation of Human Skeletal Stem Cells Differentiation by Dlk1/Pref-1
    Basem M. Abdallah, Charlotte Harken Jensen, Gloria E. Gutierrez, Robert G. Q. Leslie, Thomas Gryesten Jensen, Moustapha S Kassem · 2004 · Journal of Bone and Mineral Research
  42. Noncanonical Wnt-4 Signaling Enhances Bone Regeneration of Mesenchymal Stem Cells in Craniofacial Defects through Activation of p38 MAPK
    Jia Chang, Wataru Sonoyama, Zhuo Wang, Qiming Jin, Chengfei Zhang, Paul H. Krebsbach, William V. Giannobile, Songtao Shi, Cun-Yu Wang · 2007 · Journal of Biological Chemistry
  43. Understanding the pathology and mechanisms of type I diabetic bone loss
    Laura R. McCabe · 2007 · Journal of Cellular Biochemistry
  44. Cooperation Between TGF-β and Wnt Pathways During Chondrocyte and Adipocyte Differentiation of Human Marrow Stromal Cells
    Shuanhu Zhou, Karim Eid, Julie Glowacki · 2004 · Journal of Bone and Mineral Research
  45. Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk
    Kevin H. Qin, Michael S. Yu, Jiaming Fan, Hongwei Wang, Piao Zhao, Guozhi Zhao, Wei Zeng, Connie Chen, Yonghui Wang, Annie Wang et al. · 2023 · Genes & Diseases
  46. Effects of parathyroid hormone on Wnt signaling pathway in bone
    Nalini H. Kulkarni, David L. Halladay, Rebecca R. Miles, Linda C. Gilbert, Charles A. Frolik, Rachelle J. Sells Galvin, Thomas John Martin, Matthew T. Gillespie, Jude E. Onyia · 2005 · Journal of Cellular Biochemistry
  47. Bone Regeneration Is Regulated by Wnt Signaling
    Jae‐Beom Kim, Philipp Leucht, Kentson Lam, Cynthia A. Luppen, Derk ten Berge, Roeland Nusse, Jill Ann Helms · 2007 · Journal of Bone and Mineral Research
  48. LRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST
    Mikhail V. Semënov, Xi He · 2006 · Journal of Biological Chemistry
  49. ?-Catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation
    Gabriel Mbalaviele, Sharmin Sheikh, Joseph P. Stains, Valerie S Salazar, Su‐Li Cheng, Di Chen, Roberto Civitelli · 2004 · Journal of Cellular Biochemistry
  50. Wnt Signaling: A Key Regulator of Bone Mass
    Roland Baron, Georges Rawadi, Sergio Roman‐Roman · 2006 · Current topics in developmental biology/Current Topics in Developmental Biology
  51. Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning
    Youngwook Ahn, Brian W. Sanderson, Ophir D. Klein, Robb K. Krumlauf · 2010 · Development
  52. The two faces of serotonin in bone biology
    Patricia F. Ducy, Gérard Karsenty · 2010 · The Journal of Cell Biology
  53. Wnt signaling in neuroprotection and stem cell differentiation
    Enrique M. Toledo, Marcela Colombres, Nibaldo C. Inestrosa · 2008 · Progress in Neurobiology
  54. LRP5 and Wnt Signaling: A Union Made for Bone
    Mark L. Johnson, Kimberley Harnish, Roeland Nusse, Wim Van Hul · 2004 · Journal of Bone and Mineral Research
  55. Wnt Signaling in vascular eye diseases
    Zhongxiao Wang, Chi‐Hsiu Liu, Shuo Huang, Jing Chen · 2018 · Progress in Retinal and Eye Research
  56. Autosomal Recessive Familial Exudative Vitreoretinopathy Is Associated with Mutations in LRP5
    Xiaodong Jiao, Valerio Ventruto, Michael T. Trese, Barkur S. Shastry, James Fielding Hejtmancik · 2004 · The American Journal of Human Genetics
  57. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
    Chia‐Chen Liu, Julie L. Prior, David R Piwnica-Worms, Guojun Bu · 2010 · Proceedings of the National Academy of Sciences
  58. The WNT signalling pathway and diabetes mellitus
    Tianru Jin · 2008 · Diabetologia
  59. Where Wnts Went: The Exploding Field of Lrp5 and Lrp6 Signaling in Bone
    Bart O. Williams, Karl Leonard Insogna · 2008 · Journal of Bone and Mineral Research
  60. Heterozygous Mutations in the LDL Receptor-Related Protein 5 ( LRP5 ) Gene Are Associated With Primary Osteoporosis in Children
    Heini Hartikka, Outi Mäkitie, Minna Männikkö, Andrea Schwarz Doria, Alan Daneman, William G. Cole, Leena Ala‐Kokko, Etienne B. Sochett · 2005 · Journal of Bone and Mineral Research
  61. Structural Basis of Wnt Signaling Inhibition by Dickkopf Binding to LRP5/6
    Victoria E. Ahn, Matthew Ling-Hon Chu, Hee‐Jung Choi, Denise P. Tran, Arie Abo, William I. Weis · 2011 · Developmental Cell
  62. In Vivo Analysis of Wnt Signaling in Bone
    Donald A. Glass, Gérard Karsenty · 2007 · Endocrinology
  63. Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
    Bart Lyman Clarke · 2009 · Yearbook of Endocrinology
  64. The Fos‐related antigen Fra‐1 is an activator of bone matrix formation
    Robert Eferl, Astrid Hoebertz, Arndt Friedrich Schilling, Martina Rath, Florian A. Karreth, Lukas Kenner, Michael Amling, Erwin Friedrich Wagner · 2004 · The EMBO Journal
  65. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis
    Keizo Ohnaka, Hiroshi Taniguchi, Hisaya Kawate, Hajime Nawata, Ryoichi Takayanagi · 2004 · Biochemical and Biophysical Research Communications
  66. High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway
    Na Liu, Songtao Shi, Manjing Deng, Liang V. Tang, Guangjing Zhang, Ning Liu, Bofu Ding, Wenjia Liu, Yali Liu, Haigang Shi et al. · 2011 · Journal of Bone and Mineral Research
  67. Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells
    Carrie S. Soltanoff, Shuying Yang, Wei Chen, Yiping Li · 2009 · Critical Reviews in Eukaryotic Gene Expression
  68. Wnt Signaling in Bone Development and Disease: Making Stronger Bone with Wnts
    Jean B. Regard, Zhendong A. Zhong, Bart O. Williams, Yingzi Yang · 2012 · Cold Spring Harbor Perspectives in Biology
  69. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex
    Sara Mercurio, Branko Latinkic, Nobue Itasaki, Robb K. Krumlauf, James C. Smith · 2004 · Development
  70. T Lymphocytes Amplify the Anabolic Activity of Parathyroid Hormone through Wnt10b Signaling
    Masakazu Terauchi, Jau‐Yi Li, Brahmchetna Bedi, Ki‐Hyun Baek, Hesham A. W. Tawfeek, Sarah A. Galley, Linda C. Gilbert, Mark S. Nanes, Majd Zayzafoon, Robert E. Guldberg et al. · 2009 · Cell Metabolism
  71. Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance
    Natalie A. Terry, Kara Gross Margolis · 2016 · Handbook of experimental pharmacology
  72. Lymphoid Enhancer Factor-1 and -Catenin Inhibit Runx2-dependent Transcriptional Activation of the Osteocalcin Promoter
    Rachel A. Kahler, Jennifer J. Westendorf · 2003 · Journal of Biological Chemistry
  73. Mutations in TSPAN12 Cause Autosomal-Dominant Familial Exudative Vitreoretinopathy
    James A. Poulter, Manir Ali, David Francis Gilmour, Aine Rice, Hiroyuki Kondo, Kenshi Hayashi, David Anthony Mackey, Lisa S. Kearns, Jonathan B. Ruddle, Jamie E. Craig et al. · 2010 · The American Journal of Human Genetics
  74. Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx
    Chi Zhang · 2010 · Journal of Orthopaedic Surgery and Research
  75. Wnt pathway, an essential role in bone regeneration
    Yan Chen, Benjamin Aaron Alman · 2009 · Journal of Cellular Biochemistry
  76. The pathogenesis of the bone disease of multiple myeloma
    Claire M. Edwards, Junling Zhuang, Gregory R. Mundy · 2008 · Bone
  77. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
    Joachim Albers, Johannes Keller, Anke Baranowsky, Frank Timo Beil, Philip Catalá-Lehnen, Jochen Schulze, Michael Amling, Thorsten Schinke · 2013 · The Journal of Cell Biology
  78. TOPGAL Mice Show That the Canonical Wnt Signaling Pathway Is Active During Bone Development and Growth and Is Activated by Mechanical Loading In Vitro
    Julie R. Hens, Kimberly M. Wilson, Pamela R. Dann, Xuesong Chen, Mark C. Horowitz, John J. Wysolmerski · 2005 · Journal of Bone and Mineral Research
  79. The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease
    Xin Ye, Yanshu Wang, Jeremy Nathans · 2010 · Trends in Molecular Medicine
  80. Clinical and Molecular Findings in Osteoporosis-Pseudoglioma Syndrome
    Minrong Ai, Shauna Heeger, Cynthia F. Bartels, Deborah K. Schelling · 2005 · The American Journal of Human Genetics
  81. Knockout mouse models to study Wnt signal transduction
    Renée van Amerongen, Anton J. M. Berns · 2006 · Trends in Genetics
  82. Orally Bioavailable GSK-3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo
    Nalini H. Kulkarni, Jude E. Onyia, Qingqiang Zeng, X Y Tian, Min Liu, David Halladay, Charles A. Frolik, Thomas A. Engler, Tao Wei, Aidas Kriauciunas et al. · 2006 · Journal of Bone and Mineral Research
  83. Targeting subchondral bone for treating osteoarthritis: what is the evidence?
    Steeve Kwan Tat, Daniel Lajeunesse, Jean‐Pierre Pelletier, Johanne Martel‐Pelletier · 2010 · Best Practice & Research Clinical Rheumatology
  84. Wnt signaling in bone metabolism
    Takuo Kubota, Toshimi Michigami, Keiichi Ozono · 2009 · Journal of Bone and Mineral Metabolism
  85. Genetic Disorders of the Skeleton: A Developmental Approach
    Uwe Kornak, Stefan Mundlos · 2003 · The American Journal of Human Genetics
  86. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF
    Ken-ichi Fujita, Siegfried Janz · 2007 · Molecular Cancer
  87. Expression of LDL receptor‐related protein 5 (LRP5) as a novel marker for disease progression in high‐grade osteosarcoma
    Bang H. Hoang, Tadahiko Kubo, John H. Healey, Rebecca S. Sowers, BethAnne Mazza, Rui Yang, Andrew G. Huvos, Paul A. Meyers, Richard Greg Gorlick · 2003 · International Journal of Cancer
  88. Patients With High Bone Mass Phenotype Exhibit Enhanced Osteoblast Differentiation and Inhibition of Adipogenesis of Human Mesenchymal Stem Cells
    Weimin Qiu, Tom Erenskjold Andersen, Jens Bollerslev, Susanne Mandrup, Basem M. Abdallah, Moustapha S Kassem · 2007 · Journal of Bone and Mineral Research
  89. Melatonin regulates mesenchymal stem cell differentiation: a review
    Francesca Luchetti, Barbara Canonico, Desirée Bartolini, Marcella Arcangeletti, Silvia Ciffolilli, Giuseppe Murdolo, Marta Piroddi, Stefano Papa, Russel Joseph Reiter, Francesco Galli · 2014 · Journal of Pineal Research
  90. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?
    Rony Sapir‐Koren, Gregory Livshits · 2014 · Osteoporosis International
  91. Role of wnts in prostate cancer bone metastases
    Christopher L. Hall, Sona Kang, Ormond A. MacDougald, Evan T. Keller · 2005 · Journal of Cellular Biochemistry
  92. Skeletal cell YAP and TAZ combinatorially promote bone development
    Christopher D. Kegelman, Devon E. Mason, James H. Dawahare, Daniel J. Horan, Genevieve D. Vigil, Scott S. Howard, Alexander G. Robling, Teresita Bellido, Joel D. Boerckel · 2018 · The FASEB Journal
  93. The WNT signaling pathway from ligand secretion to gene transcription: Molecular mechanisms and pharmacological targets
    Hoeke Abele Baarsma, Mélanie Königshoff, Reinoud Gosens · 2013 · Pharmacology & Therapeutics
  94. Wnt/Frizzled signaling in angiogenesis
    Marielba Zerlin, Martin A. Julius, Jan Kitajewski · 2008 · Angiogenesis
  95. Controlling mesenchymal stem cell differentiation by TGFβ family members
    Bernard A.J. Roelen, Peter ten Dijke · 2003 · Journal of Orthopaedic Science
  96. Mesenchymal Stem Cells: Molecular Targets for Tissue Engineering
    Neeraj Kumar Satija, G.U. Gurudutta, Shilpa Sharma, Farhat Afrin, Pallavi Gupta, Yogesh Kumar Verma, Vimal Kishor Singh, RP Tripathi · 2007 · Stem Cells and Development
  97. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging
    Mark R. Haussler, Carol A. Haussler, G. Kerr Whitfield, Jui‐Cheng Hsieh, Paul D. Thompson, Thomas K. Barthel, Leonid Bartik, Jan B. Egan, Yifei Wu, Jana L. Kubicek et al. · 2010 · The Journal of Steroid Biochemistry and Molecular Biology
  98. LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence
    Qian Ren, Jiongcheng Chen, Youhua Liu · 2021 · Frontiers in Cell and Developmental Biology
  99. Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types
    Milena Jovanovic, Gali Guterman Ram, Joan C. Marini · 2021 · Endocrine Reviews
  100. The Low-Density Lipoprotein Receptor-Related Protein 1 Is a Mitogenic Receptor for Lactoferrin in Osteoblastic Cells
    Andrew B. Grey, Tatjana Banovic, Qing Zhu, Maureen Watson, Karen E. Callon, Kate Palmano, Jacqueline Ross, Dorit Naot, Ian R. Reid, Jillian Cornish · 2004 · Molecular Endocrinology